SMR 2 Acute Red Eye
SMR 2 Acute Red Eye
PREPARED BY :-
ARAVENDGANESH A/L RAMAKRISHANAN - 012021100120
JULIAN NATANIELL PARAMAKURU - 012021100164
LADY ANNIE ARUNA KIANE MANEKA HENDRICKS - 012021100174
SREE VAASNI A/P NARASIMMAN - 012021100012
THIVYAN A/L KANNAN - 012021100121
YASMIN NABILAH BINTI BUSERAH - 012020100020
CONJUNCTIVITIS
SREE VAASNI NARASIMMAN - 012021100012
JULIAN NATANIELL PARAMAKURU - 012021100164
CONJUNCTIVITIS
● ‘PINK EYE’
CLASSIFICATION
VIRAL BACTERIAL
● ALLERGIC
● SUBACUTE ● TOXINS/ CHEMICAL
● ACUTE ● FOREIGN BODY
● CHRONIC ● TRAUMA
● NEOPLASM
VIRAL CONJUNCTIVITIS
Epidemic
keratoconjunctivitis
SYMPTOMS
Redness
Discharge
Itchiness
Photophobia
SIGNS
SIGNS
INVESTIGATION
● Giemsa stain
● Nucleic acid amplification —> PCR
● Viral culture
● ‘Point care’ immunochromatography
● Serology - IgM or IgG
MANAGEMENT
● Spontaneous resolution
● Reduction of transmission risk
● Molluscum contagiosum - removal
● Topical steroids - severe membranous or
pseudomembranous adenoviral conjunctivitis (monitor IOP
)
● Treat the risk factors such as discontinuation of contact
lens
● Others : artificial tears, cold or warm compress,
antihistamine
ACUTE BACTERIAL CONJUNCTIVITIS
Redness
Discharge
Burning
Bilateral & eyelids stuck together
SIGNS
Lid edema
Mucopurulent Discharge
Blepharitis
Conjunctival hyperaemia
INVESTIGATION
● binocular conjunctival swabs and scrapping
● Culture should include enriched media such as
chocolate agar or Thayer–Martin for N. gonorrhoeae
● Polymerase chain reaction (PCR
TREATMENT
● Topical antibiotics
● Systemic antibiotics
● Topical steroid
● Irrigation
● Reduce the t risk of transmission
● Review
● Statutory notification of public health authorities
- Acute Allergic Conjunctivitis
- Seasonal & Perennial Allergic
Conjunctivitis
- Vernal Keratoconjunctivitis (VKC)
Allergic - Atopic Keratoconjunctivitis (AKC)
Treatment - Treatment
- Artificial tears
- Mast cell stabilisers
- Antihistamines
- Topical steroids
Signs & Symptoms
● Thick mucus
● Discharge
Vernal ● Pain
Keratoconjunctivitis ●
●
Lacrimation
Photophobia
(VKC) ● Blurred vision
● Foreign body sensation
Vernal Keratoconjunctivitis (VKC)
Palpebral
- Vernal means ‘spring’
- Usually affects people in warm, dry
weather
- Usually seen in prepubescent males
- Classification
- Palpebral
- Limbal
- Keratopathy
A. Macropapillae resembling cobblestone
(Focal)
B. Diffuse inflammatory infiltrate
C. Progresses to giant papillae
D. Mucus deposition in between papillae
(AKC)
Atopic Keratoconjunctivitis (AKC)
Is a rare disease that typically develops in adulthood
following a long history of atopy (dermatitis & asthma)
E. Peripheral vascularisation
- Hertoghe sign:
- Absence of the lateral portion of the
eyebrows
- Dennie-Morgan folds:
- Lid skin folds caused by persistent
rubbing
Treatment of VKC & AKC
General Local Systemic Surgical
+ Iris -
-
Iritis
Anterior cyclitis
+ Ciliary Body - Iridocyclitis
Granulomatous Non-granulomatous
(Exudative)
Organisms lodged in some other organ of the body reach the eye through the bloodstream.
Bacterial
Allergic-inflammation / Hypersensitivity reaction - Therefore uveitis occurs commonly in association with: rheumatoid arthritis, systemic lupus
erythematosus, sarcoidosis, ankylosing spondylitis, Reiter’s disease, Behcet’s syndrome.
- Patient with HLA-B27 allele
Signs
Anterior Uveitis 1. Ciliary flush - Active hyperemia of
Symptoms anterior ciliary blood vessels
1. Painful Red eye congestion due to inflammation
- Inflammation of iris and ciliary body
2. Photophobia
- Iris very sensitive to stimulation due
to many nerve fibers
- Excessive pupillary constriction and 2. Keratic precipitate - Inflammation
ciliary spasm causing Irritation causing nutrition deficit of the corneal
3. Blurry vision endothelium causing desquamation
- Present of hazy plasmoid aqueous and sticky. Inflammatory cells form in
and keratic precipitate triangle pattern with apex in superior
4. Increase tear production / watery (arlt triangle) due to aqueous
discharge convection current and gravity.
Signs Cont.
● Aqueous Flare
- Aqueous become haziness due to inflammatory exudate that contain
leucocyte, coagulated protein and in severe form fibrin
● Hyphema
- When blood collects between the clear front part of the eye (cornea)
and the colored part of the eye (iris)
● Hypopyon
- The accumulation of white blood cells that form a whitish layer of fluid
in the lower portion of the eye anterior chamber (front part)
Signs Cont.
● Miosis
- Inflammation of iris causing dilation of blood vessel lead to plasma
leakage causing excessive mechanical constriction
- Inflammation also cause overstimulation lead to muscle spasm
● Koeppe nodule
- Inflammatory cell precipitates which lie at the pupillary margin and could
be found in non-granulomatous as well as granulomatous uveitis
● Busacca nodule
- Modules that lies on the iris surface which are pathognomonic for
granulomatous uveitis
Posterior Uveitis
- Inflammation of the posterior uveal tract (choroid).
- Lesion can primary to adjacent structure like retina and blood vessel
- Location of lesion may be:
● Focal
● Multifocal
● Diffuse
- Symptoms (Impaired vision)
● Positive scotoma
Floaters Scotoma
● Negative scotoma
● Floaters
- Signs
● Retinitis
● Choroiditis
Retinitis Choroiditis
Investigations
Hematological Tests Sampling
- HLA Tissue Typing (HLA-B27) - Aqueous Tap
- CBC, ESR, CRP - Iris Biopsy
- Serology: Syphilis, HIV, Lyme disease - Vitreous Biopsy
- Serum ACE, Lysozyme - Conjunctival Biopsy
- ANA, ANCA, IGRA
Imaging Ocular:
- B-scan
- OCT
- FAF
- FA
- ICGA
- UBM
General:
- Chest X-Ray & Sacroiliac Joint X-Ray
Complications
1. Complicated Cataract
3. Cyclitic Membrane
- Fibrovascular proliferations that extend
from the inner side of the ciliary body to
the vitreous base and the peripheral retina
Complications
5. Phthisis bulbi
Subconjunctival:
- Indications: Severe cases, Poor compliance.
Betamethasone Sodium Phosphate solution (4 mg in 1 ml).
Regional (Periocular):
- Indications: Severe cases, Poor compliance, Adjunct of therapy in
resistant CAU.
Methylprednisolone/Triamcinolone at sub-tenon space (40–80 mg).
Intraocular:
- Indications: AU for CMO unresponsive to other forms of therapy.
Intravitreal Triamcinolone Acetonide (4 mg in 0.1 ml).
Systemic:
- Indications: Severe cases, Stagnant on max topical & periocular.
Prednisolone 1–1.5 mg/kg 4x/day x1–2 weeks → Taper over 5–6 weeks.
Treatment Cont.
Cycloplegic Agent/MyDriatic Eye Drops Cycloplegic Agents:
- Indications: AAU, Exacerbation of CAU.
- Cyclopentolate (12–24 hours), Homatropine (3
days), Atropine (7–10 days), Phenylephrine 2.5% or
10%.
Tissue Plasminogen Activator (TPA) For severe fibrinous anterior uveitis: 12.5–25 μg in
0.1 ml injected into AC.
References
- Yang, P. (2021). Complications and Their Management. In: Atlas of Uveitis. Springer, Singapore.
https://doi.org/10.1007/978-981-15-3726-4_11
- Weinberg RS. Anterior uveitis. Ophthalmol Clin North Am 1993; 6(1):23-8
- Salmon, John F. Kanski's Clinical Ophthalmology: A Systematic Approach. Elsevier, 2020.
SUBCONJUNCTIVAL
HEMORRHAGE
YASMIN NABILAH - 012020100020
SUBCONJUNCTIVAL HEMORRHAGE
What is subconjunctival hemorrhage?
DEFINITION
A condition where blood leaks from small blood vessels beneath the
conjunctiva.
CAUSES
● Trauma
● Surgery
● Severe eye infections
● Mechanical straining (e.g violent coughing, sneezing, vomiting, lifting
heavy weights)
● Eye rubbing
SUBCONJUNCTIVAL HEMORRHAGE
ETIOLOGY & RISK FACTORS
Age-related association
● Younger individual
Use of contact lens.
● Older individual
Systemic vascular disease (e.g hypertension, diabetes mellitus).
Other risk factors
● Use of Aspirin or platelet-affecting medications.
● Rare association
➔ Bleeding diathesis
➔ Vitamin C deficiency
➔ Abusive trauma
SUBCONJUNCTIVAL HEMORRHAGE
CLINICAL PRESENTATION
Symptoms Signs
Unaffected vision
SUBCONJUNCTIVAL HEMORRHAGE
DIFFERENTIAL DIAGNOSIS
● Periocular hematoma
● Retrobulbar hemorrhage
SUBCONJUNCTIVAL HEMORRHAGE
Acute hemorrhagic conjunctivitis
A highly contagious viral eye infection that usually occurs in tropical area, typically caused by enterovirus
and coxsackievirus. It usually benign and may resolves within 1 to 2 weeks.
Symptoms
● Rapid onset of severe conjunctivitis
● Subconjunctival hemorrhage
Management
● Prevent undue alarm and discourage home remedies
● Control the spread
Complications (rare)
● Polio-like paralysis (about 1 in 10,000 cases)
SUBCONJUNCTIVAL HEMORRHAGE
Periocular hematoma
Also known as “black eye” and is involves localized hematoma and/ or periocular ecchymosis (diffuse
bruising) due to blunt trauma.
A rare complication of retrobulbar anaesthesia in cataract surgery, where bleeding occurs in retrobulbar
space and caused subconjunctival hemorrhage as blood spreads under the conjunctiva.
So, small incision cataract surgery can be safely performed following limited retrobulbar hemorrhage.
SUBCONJUNCTIVAL HEMORRHAGE
INVESTIGATIONS
● Autoimmune workup
SUBCONJUNCTIVAL HEMORRHAGE
MANAGEMENT
● Kanski, J. J., Bowling, B., Nischal, K. K., & Pearson, A. (2020). Clinical ophthalmology: A
● Wright PW, Strauss GH, Langford MP. Acute hemorrhagic conjunctivitis. Am Fam Physician. 1992
Classification
(based on route of infection)
● Post-operative ● Hematogenous
● Trauma dissemination and spread
● Post-intravitreal injection from a distant infective
● Bleb-related source in the body.
Risk factors
Systemic Local
● Diabetes mellitus ● Blepharitis, conjunctivitis,
● Host Immunosuppression dacryocystitis, lacrimal duct
● Use of immunosuppressive obstruction etc.
drugs (e.g. corticosteroids) ● Contact lens wearer
● Ocular prosthesis
● Trauma: Delay in primary
repair, retained IOFB , the
position and extent of
wounds.
Risk factors
Operative risk factors
Intraoperative Postoperative
Fungal
● Candida spp.
● Aspergillus spp.
Symptoms
● Blurring of vision
● Ocular pain
● Ocular redness
● Eye discharge
● Eyelid swelling
● Photophobia
Signs
● Visual acuity: decreased
● Eyelids swelling
● Conjunctival injection, chemosis and
discharge
● Corneal oedema
● Anterior chamber: Fibrinous exudate &
hypopyon
● Vitreous clouding (vitritis) - impaired
view of fundus
● Loss of red reflex
Signs
Systemic antibiotics
● Intravenous antibiotics of the same choice as
intravitreal antibiotics can be used in severe
virulent endophthalmitis.
● Alternatively, oral fluoroquinolones (penetrate
the eye well) and moxifloxacin is also
recommended.
● Oral clarithromycin - for culture negative
infections
Management
Corticosteroids Topical Cycloplegics
● Limit destructive complications of the inflammatory ● E.g. atropine 1% - relieve
process. ciliary body spasms
● Topical (dexamethasone 0.1%), intravitreal
(dexamethasone), or systemic (Prednisolone
1mg/kg).
● Fungal infection to be excluded before Anti-glaucoma agents
administering prednisolone.
● E.g. timolol - reduce
intraocular pressure
Vitrectomy
● Immediate pars plana vitrectomy for patient with perception of light (not
hand movements vision or better) at presentation.
● It should also be considered if the clinical signs are worsening.
Postoperative Endophthalmitis
Prophylaxis
5%
Treatment of pre-existing
povidone-iodine
infections
For the preparation of
skin and conjunctival
sac Early resuturing of
Scrupulous leaking wounds
preparation of the
surgical site Reviewing
personal surgical
practice
Antibiotic prophylaxis
e.g. Intracameral cefuroxime (1 mg
in 0.1 ml) injected into the
AC at the end of surgery.
Management
Chronic postoperative
endophthalmitis
Intravitreal antibiotics
● Vancomycin is the antibiotic of choice.
● P. acnes is also sensitive to methicillin,
cefazolin and clindamycin.
Vitrectomy
● Often requires pars plana vitrectomy
and removal of the capsular bag and/or
IOL.
● Secondary IOL implantation may be
considered at a later date.
Management
Fungal Traumatic
endophthalmitis endophthalmitis
Antifungal ● Open globe injuries: Give
● Intravenous amphotericin-B in prophylactic antibiotics (e.g.
combination with oral flucytosine ciprofloxacin 750 mg twice daily or
(resistance is a concern). moxifloxacin 400 mg once daily)
● Voriconazole (orally or intravenously) - together with topical antibiotic,
broad spectrum antifungal with low steroid and cycloplegia.
reported resistance and high ocular ● High-risk cases (e.g. agricultural
penetration. injuries): Give prophylactic
● Adjunctive intravitreal treatment may be intravitreal antibiotics
given(100 µg in 0.1 ml). ● Prompt removal of a retained IOFB.
● Treatment for established cases is
Pars plana vitrectomy the same as for acute postoperative
● Consider vitrectomy at an early stage, bacterial endophthalmitis.
especially for severe or unresponsive
disease.
Complications
● Panophthalmitis
● Phthisis bulbi
● Retinal necrosis
● Retinal detachment
● Secondary glaucoma
References
● Salmon, J. F. (2020). Kanski’s Clinical Ophthalmology (9th ed.). Elsevier.
● Clinical Practice Guidelines: Management of Post-operative Infectious
Endophthalmitis (2006)
● Durand, M. L. (2013). Endophthalmitis. Clinical Microbiology and Infection, 19(3),
227-234.
● Kernt, M., & Kampik, A. (2010). Endophthalmitis: pathogenesis, clinical presentation,
management, and perspectives. Clinical Ophthalmology, 121-135.
● Sadiq, M. A., Hassan, M., Agarwal, A., Sarwar, S., Toufeeq, S., Soliman, M. K., ... &
Nguyen, Q. D. (2015). Endogenous endophthalmitis: diagnosis, management, and
prognosis. Journal of ophthalmic inflammation and infection, 5, 1-11.
Pterygium
THIVYAN KANNAN - 012021100121
Background
● A pterygium is a triangular fibrovascular sub-epithelial ingrowth of degenerative bulbar conjunctival tissue
that grows over the limbus onto the cornea.
● Nasal part of bulbar conjunctiva more commonly affected than temporal par
Etiology
● Primarily driven by ultraviolet (UV) radiation exposure, which damages limbal stem cells,
alters fibroblast behavior, and induces inflammatory responses, leading to tissue remodeling
and progression of the condition.
● Hereditary, with different inheritance patterns suggested, including genes like MMP-1 and
factors related to blood vessel growth; microRNAs may also play a role, but the exact
genetic causes are still not fully understood.
● Viral agents, particularly human papillomavirus (HPV) and herpes simplex virus (HSV), may
play a role in the development of pterygium in genetically susceptible individuals
Risk factors
● Ultraviolet (UV) Exposure:
● Environmental Factors:
● Lifestyle/ Occupational Factors
● Genetic Predisposition
● Sex : Male:Female = 2:1
Symptoms Signs
● Mostly small lesions are ● Triangular pinkish growth
asymptomatic ○ Base: lies within the interpalpebral
● Irritation and a gritty sensation, conjunctiva
● Foreign body sensation ○ Apex: encroaches upon the cornea
● Congestion, dryness ● Diplopia on Lateral Gaze
● Visual disturbance ● Acquired Astigmatism
● Impaired vision
Types of pterygium
Progressive Atrophic
● Thick, fleshy with prominent ● Thin, Attenuated, with poor
vascularity vascularity
● Gradually increasing in size and
encroaching towards the centre of ● No opaque spot (cap) is seen
the cornea ● Stationary
● Opaque infiltrative spot (cap) seen ● Ultimately it becomes
just in front of the apex of the membranous but never
pterygium
disappears
● Deposition of iron as a line
(Stocker's line) is seen in corneal
epithelium infrage 16 of the apex.
Progressive Atropic
Clinical Classification
Tan’s Classification of pterygium
Clearly visible episcleral blood Partially visible episcleral blood Totally obscured episcleral blood
vessels under the body of the vessels under the body of the vessels under the body of the
pterygium pterygium. pterygium
True Pterygium Pseudopterygium
Typically grows horizontally, often nasally Can occur anywhere along the corneal
Site
periphery
Progressive, can invade Bowman’s layer Non-progressive, does not invade deeper
Growth pattern
layers
Adherence Firmly adherent to the limbus May have free edges,can pass a probe underneath
Surgical Management
1. Simple Excision (Bare Sclera Technique):
● High recurrence rate (~80%).
● Leaves bare sclera after removal.
2. Conjunctival Autografting:
● Uses a graft from the superior or upper-temporal conjunctiva.
● Can be secured with sutures or tissue glue, reducing irritation and recovery time.
● Lower recurrence rates compared to simple excision.
3. Adjunctive Treatments:
● Mitomycin C (MMC): Reduces recurrence risk.
● Beta-irradiation: Alternative adjunctive therapy.
4. Peripheral Lamellar Keratoplasty:
● Indicated for deeper lesions.
References
● Kanski, J. J., Bowling, B., Nischal, K. K., & Pearson, A. (2020). Clinical ophthalmology: A
systematic approach (9th ed.).
● Shahraki, T., Arabi, A., & Feizi, S. (2021, May 31). Pterygium: An update on
pathophysiology, clinical features, and Management. Therapeutic advances in
ophthalmology.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8170279/#section11-25158414211020152
● Shahraki, T., Arabi, A., & Feizi, S. (2021b, May 31). Pterygium: An update on
pathophysiology, clinical features, and Management. Therapeutic advances in
ophthalmology.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8170279/#section11-25158414211020152